8-KMaterial AgreementsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Material Agreement (Aug 1, 2006)

Filed August 1, 2006For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on August 1, 2006, detailing material changes to its executive compensation and employment agreements. The most significant development is the amendment and restatement of the employment contract for Dr. Surya N. Mohapatra, the company's President, CEO, and Chairman. This amended contract extends his term for five years, concluding on December 31, 2011, and enhances his bonus potential and severance provisions, offering increased security and incentive for continued leadership. Furthermore, the company has amended its Supplemental Executive Retirement Plan for Dr. Mohapatra. These changes include an increased accrual rate for service periods after July 31, 2006, a revised method for calculating final average pay to incorporate bonuses over a three-year period, and enhanced credited service in specific termination scenarios, particularly after age 60. These adjustments to Dr. Mohapatra's compensation and retirement benefits signal a commitment to retaining key executive talent and aligning executive interests with long-term company performance.

Key Highlights

  • 1Quest Diagnostics has amended and restated the employment contract for CEO Dr. Surya N. Mohapatra, extending his term by five years to December 31, 2011.
  • 2Dr. Mohapatra's target bonus percentage will increase to 150% of base salary beginning January 1, 2007.
  • 3The amended employment contract includes provisions for Dr. Mohapatra to receive severance if Quest Diagnostics fails to renew the contract until 2015.
  • 4The company is amending its Supplemental Executive Retirement Plan for Dr. Mohapatra, increasing the benefit accrual rate for service post-July 31, 2006, to 2.2% from 1.5%.
  • 5The calculation of 'final average pay' for the retirement plan will now use salary and bonus from the highest three consecutive calendar years within the last five, a change from the previous method using salary and last three annual bonuses.
  • 6The retirement plan includes enhanced credited service provisions for Dr. Mohapatra under specific termination conditions (without Cause or for Good Reason) after age 60.
  • 7Quest Diagnostics also agreed to pay Dr. Mohapatra a special $100,000 cash bonus as part of these arrangements.

Frequently Asked Questions

This 8-K filing announces material changes to the employment agreement and supplemental executive retirement plan for Quest Diagnostics' CEO, Dr. Surya N. Mohapatra, primarily concerning an extension of his employment term and modifications to his compensation and retirement benefits.

The contract term has been extended by five years to December 31, 2011. Additionally, his target bonus potential increases to 150% of base salary from January 1, 2007, and he is entitled to severance if the contract isn't renewed until 2015.

The retirement plan's accrual rate for service after July 31, 2006, increases to 2.2%. The 'final average pay' calculation method is updated to include salary and bonus from the highest three of the last five years, and there are enhanced credited service provisions for specific termination scenarios after age 60.

Yes, the extension of the CEO's contract and the enhancements to his compensation and retirement benefits suggest the company's commitment to retaining its key executive leadership, implying a focus on stability and long-term strategic execution.